Patent ID: 8034343
Filing Date: 2011-10-11
Classification: A61K,A61P,C07K

Abstract:
1. A method of treating an inflammatory disorder of the lungs, the method comprising administering to a patient an effective amount of a composition comprising an antibody specific for a polypeptide consisting of an amino acid sequence selected from the group consisting of: (a) −19 to 522 of SEQ ID NO:2; (b) 1 to 522 of SEQ ID NO:2; (c) −19 to 310 of SEQ ID NO:2; (d) 1 to 310 of SEQ ID NO:2 and (e) the amino acid sequence set forth in any one of a)-d) above, with the exception that amino acid 298 is deleted, wherein the inflammatory disorder of the lungs is an inflammatory disorder of the lung associated with allergy, an inflammatory disorder of the lung associated with asthma, or adult respiratory distress syndrome.